A Change in Administrations Underlines the Stakes of an E-Cigarette Case SCOTUS Heard This Week
An e-liquid manufacturer is challenging the FDA's "arbitrary and capricious" rejection of flavored vaping products.
An e-liquid manufacturer is challenging the FDA's "arbitrary and capricious" rejection of flavored vaping products.
Both Donald Trump and Kamala Harris support supply-side tactics that are worse than ineffective.
One thing seems clear: Drug warriors do not deserve credit for the turnaround, although they deserve blame for the previous explosion in fatal overdoses.
The Democratic vice presidential nominee has a long record of supporting cannabis reform.
The 5th Circuit ruled that the agency violated the Administrative Procedure Act when it rejected applications from manufacturers of flavored nicotine e-liquids.
The Harm Reduction Gap argues for individual autonomy and meeting drug users where they're at.
The agency's inscrutable approach to harm-reducing nicotine products sacrifices consumer choice and public health on the altar of youth protection.
Recent research finds "no evidence" that it did, undermining a key claim by critics of that policy.
Policies inspired by that exaggerated threat continue to undermine the harm-reducing potential of e-cigarettes.
A study found a "high rate of substitution" between vapes and cigarettes, suggesting that policies aimed at preventing underage use are undermining public health.
Many of the problems the state is experiencing are caused by the continuing impact of prohibition.
"Government in general does a lot of things that aren't necessary," says Jared Polis.
While the lethal effects of Iran’s booze ban are widely recognized, politicians ignore similar consequences from U.S. drug laws.
A study suggests that "selectively targeting large-scale drug vendors" on the dark web can succeed where all previous enforcement efforts have failed.
The emergence of the animal tranquilizer as an opioid adulterant illustrates once again how the war on drugs makes drug use more dangerous.
Even the best studies haven't surmounted a key statistical issue, and they tend to distort the evidence to make e-cigarettes look dangerous.
The appeals court says regulators violated the Administrative Procedure Act when they tried to pull menthol vapes off the market.
Thanks to tendentiously sloppy research, most Americans think vaping is just as dangerous as smoking. That’s not true.
The paper pushes modest reforms while endorsing continued criminalization.
Plus: The editors consider the ongoing debt ceiling drama and answer a listener question about ending the war on drugs.
As the drug war retreats, individualist approaches to substance use and abuse will make us all better off.
Andrew Tatarsky and Maia Szalavitz push individualist approaches to substance abuse as the drug war retreats.
The obvious problems with the article reflect a broader pattern that suggests a peer review bias against e-cigarettes.
The agency is determined to ban the flavors that former smokers overwhelmingly prefer. For the children.
The failure to consider the timing of diagnoses makes it impossible to draw causal inferences.
Naloxone could be available without a prescription by spring.
Plus: Lawmakers "demanding action" against slurs on Twitter, FTC sues to stop Microsoft from buying Activision Blizzard, and more...
By making e-cigarettes less appealing, it will discourage smokers from switching to a much less hazardous nicotine habit.
The CDC is still citing underage consumption as a reason to restrict adult access.
Don’t expect a change in course, despite the long-awaited admission.
The state is prioritizing harm-reduction approaches for drug users. That's great. So why are lawmakers taking a maximalist approach to punishing smokers?
The "epidemic" of adolescent vaping seems to be fading fast, and vaping is replacing smoking among adults, a harm-reducing trend that regulators seem determined to discourage.
Supervised facilities aim to make a dent in the dramatic increase in overdose deaths.
The agency’s policies would boost the black market and smoking-related deaths.
According to new CDC numbers, the death toll rose 15 percent last year after jumping 30 percent in 2020.
In a move that is likely to undermine public health, the agency warns that products containing synthetic nicotine "will be subject to FDA enforcement."
The agency's obsession with adolescent vaping is driving decisions that undermine public health.
The agency ignores downward trends in both kinds of nicotine use and obscures the huge difference in the hazards they pose.
A spending bill provision would redefine "tobacco products" to include products that have nothing to do with tobacco.
Stranger still, the leading drug policy reform organization supported Schumer's obstruction.
The findings reinforce the case for nicotine vaping products as a harm-reducing alternative to cigarettes.
The perverse provision would have discouraged smokers from switching to a far less hazardous source of nicotine.
Less punitive responses to drug addiction are good, but what about people still stuck in federal prison?
As the U.S. reaches new terrible milestones in overdose deaths, a harm reduction system that has proven itself elsewhere finally launches where it’s needed most.
Cigarette sales rose last year for the first time in two decades, while a survey of high school seniors found they were vaping less but smoking more.
If teenagers like an e-liquid flavor, the agency seems to think, adults should not be allowed to buy it.
The agency seems inclined to ban the vaping products that former smokers overwhelmingly prefer because teenagers also like them.
Although Raja Krishnamoorthi says "adults can do what they want," he is determined not to let them.
Do you care about free minds and free markets? Sign up to get the biggest stories from Reason in your inbox every afternoon.
This modal will close in 10